Back

MCLA-128 AACR Poster (April 2017)

The binding mode of the bispecific anti-HER2xHER3 antibody MCLA-128 is responsible for its potent inhibition of HRG-driven tumorigenesis

David Maussang, Camilla De Nardis, Linda Hendriks, Carina Bartelink-Clements, Nellie Nieuwenhuizen, Eric Rovers, Tristan Gallenne, Robert Doornbos, Lex Bakker, Ton Logtenberg, John de Kruif, Piet Gros, Cecile Geuijen, and Mark Throsby